Expert appraisal of criteria for assessing gaming disorder: an international Delphi study.


Journal

Addiction (Abingdon, England)
ISSN: 1360-0443
Titre abrégé: Addiction
Pays: England
ID NLM: 9304118

Informations de publication

Date de publication:
09 2021
Historique:
revised: 23 09 2020
received: 26 05 2020
accepted: 06 01 2021
pubmed: 16 1 2021
medline: 1 10 2021
entrez: 15 1 2021
Statut: ppublish

Résumé

Following the recognition of 'internet gaming disorder' (IGD) as a condition requiring further study by the DSM-5, 'gaming disorder' (GD) was officially included as a diagnostic entity by the World Health Organization (WHO) in the 11th revision of the International Classification of Diseases (ICD-11). However, the proposed diagnostic criteria for gaming disorder remain the subject of debate, and there has been no systematic attempt to integrate the views of different groups of experts. To achieve a more systematic agreement on this new disorder, this study employed the Delphi expert consensus method to obtain expert agreement on the diagnostic validity, clinical utility and prognostic value of the DSM-5 criteria and ICD-11 clinical guidelines for GD. A total of 29 international experts with clinical and/or research experience in GD completed three iterative rounds of a Delphi survey. Experts rated proposed criteria in progressive rounds until a pre-determined level of agreement was achieved. For DSM-5 IGD criteria, there was an agreement both that a subset had high diagnostic validity, clinical utility and prognostic value and that some (e.g. tolerance, deception) had low diagnostic validity, clinical utility and prognostic value. Crucially, some DSM-5 criteria (e.g. escapism/mood regulation, tolerance) were regarded as incapable of distinguishing between problematic and non-problematic gaming. In contrast, ICD-11 diagnostic guidelines for GD (except for the criterion relating to diminished non-gaming interests) were judged as presenting high diagnostic validity, clinical utility and prognostic value. This Delphi survey provides a foundation for identifying the most diagnostically valid and clinically useful criteria for GD. There was expert agreement that some DSM-5 criteria were not clinically relevant and may pathologize non-problematic patterns of gaming, whereas ICD-11 diagnostic guidelines are likely to diagnose GD adequately and avoid pathologizing.

Sections du résumé

BACKGROUND AND AIMS
Following the recognition of 'internet gaming disorder' (IGD) as a condition requiring further study by the DSM-5, 'gaming disorder' (GD) was officially included as a diagnostic entity by the World Health Organization (WHO) in the 11th revision of the International Classification of Diseases (ICD-11). However, the proposed diagnostic criteria for gaming disorder remain the subject of debate, and there has been no systematic attempt to integrate the views of different groups of experts. To achieve a more systematic agreement on this new disorder, this study employed the Delphi expert consensus method to obtain expert agreement on the diagnostic validity, clinical utility and prognostic value of the DSM-5 criteria and ICD-11 clinical guidelines for GD.
METHODS
A total of 29 international experts with clinical and/or research experience in GD completed three iterative rounds of a Delphi survey. Experts rated proposed criteria in progressive rounds until a pre-determined level of agreement was achieved.
RESULTS
For DSM-5 IGD criteria, there was an agreement both that a subset had high diagnostic validity, clinical utility and prognostic value and that some (e.g. tolerance, deception) had low diagnostic validity, clinical utility and prognostic value. Crucially, some DSM-5 criteria (e.g. escapism/mood regulation, tolerance) were regarded as incapable of distinguishing between problematic and non-problematic gaming. In contrast, ICD-11 diagnostic guidelines for GD (except for the criterion relating to diminished non-gaming interests) were judged as presenting high diagnostic validity, clinical utility and prognostic value.
CONCLUSIONS
This Delphi survey provides a foundation for identifying the most diagnostically valid and clinically useful criteria for GD. There was expert agreement that some DSM-5 criteria were not clinically relevant and may pathologize non-problematic patterns of gaming, whereas ICD-11 diagnostic guidelines are likely to diagnose GD adequately and avoid pathologizing.

Identifiants

pubmed: 33449441
doi: 10.1111/add.15411
pmc: PMC8451754
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2463-2475

Subventions

Organisme : Wellcome Trust
ID : 110 049/Z/15/Z
Pays : United Kingdom

Informations de copyright

© 2021 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Références

J Affect Disord. 2014 Mar;156:67-75
pubmed: 24359862
Schizophr Bull. 2008 May;34(3):435-43
pubmed: 17768307
World Psychiatry. 2018 Oct;17(3):363-364
pubmed: 30192089
Neurosci Biobehav Rev. 2019 Sep;104:1-10
pubmed: 31247240
Addiction. 2014 Sep;109(9):1399-406
pubmed: 24456155
Curr Psychiatry Rep. 2015 Sep;17(9):72
pubmed: 26216590
Schizophr Bull. 2014 Nov;40(6):1347-55
pubmed: 24727194
BMC Med Res Methodol. 2005 Dec 01;5:37
pubmed: 16321161
Psychiatr Serv. 2013 May 1;64(5):452-7
pubmed: 23370444
Nature. 2019 Sep;573(7774):346
pubmed: 31530926
J Behav Addict. 2017 Sep 1;6(3):285-289
pubmed: 28816514
J Psychiatr Res. 2014 Jun;53:103-10
pubmed: 24581573
J Behav Addict. 2020 Apr 01;9(1):1-13
pubmed: 32359228
Addiction. 2018 Nov;113(11):2145-2146
pubmed: 30007117
J Behav Addict. 2019 Mar 1;8(1):16-24
pubmed: 30663331
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16569-72
pubmed: 16275915
J Clin Med. 2019 Jun 28;8(7):
pubmed: 31261841
Addiction. 2016 Jan;111(1):167-75
pubmed: 26669530
Psychiatry Clin Neurosci. 2017 Jul;71(7):445-458
pubmed: 27193187
Can J Nurs Adm. 1994 Sep-Oct;7(3):29-42
pubmed: 7880844
Clin Psychol Rev. 2016 Feb;43:58-66
pubmed: 26704173
Am J Psychiatry. 2017 Mar 1;174(3):230-236
pubmed: 27809571
Cognition. 2015 Sep;142:191-204
pubmed: 26046424
J Behav Addict. 2017 Sep 1;6(3):267-270
pubmed: 28033714
Aust N Z J Psychiatry. 2015 Oct;49(10):887-97
pubmed: 26296368
BMJ. 1995 Aug 5;311(7001):376-80
pubmed: 7640549
Curr Opin Psychol. 2020 Dec;36:49-54
pubmed: 32480020
Transcult Psychiatry. 2019 Aug;56(4):748-774
pubmed: 31084279
Addiction. 2019 Jun;114(6):1095-1109
pubmed: 30133930
BMC Psychiatry. 2014 Sep 13;14:241
pubmed: 25213799
Addiction. 2015 May;110(5):842-51
pubmed: 25598040
J Behav Addict. 2019 Jun 1;8(2):288-294
pubmed: 31120319
Am J Med Qual. 2006 Nov-Dec;21(6):382-93
pubmed: 17077420
J Behav Addict. 2016 Sep;5(3):474-84
pubmed: 27554504
J Behav Addict. 2018 Mar 1;7(1):1-9
pubmed: 29529886
Addiction. 2017 Oct;112(10):1709-1715
pubmed: 28198052
J Behav Addict. 2018 Sep 1;7(3):556-561
pubmed: 30010410
Addiction. 2016 Jan;111(1):175-8
pubmed: 26669531
Addiction. 2021 Sep;116(9):2463-2475
pubmed: 33449441
Clin Psychol Rev. 2014 Jun;34(4):298-308
pubmed: 24786896
J Clin Epidemiol. 2014 Apr;67(4):401-9
pubmed: 24581294
J Behav Addict. 2017 Sep 1;6(3):271-279
pubmed: 28816494
Addiction. 2017 Oct;112(10):1723-1724
pubmed: 28891143
Addict Behav. 2018 Jul;82:114-121
pubmed: 29522932
J Behav Addict. 2015 Sep;4(3):119-23
pubmed: 26014667
J Behav Addict. 2017 Jun 1;6(2):103-109
pubmed: 27599673

Auteurs

Jesús Castro-Calvo (J)

Department of Personality, Assessment, and Psychological Treatments, University of Valencia, Spain.

Daniel L King (DL)

College of Education, Psychology, and Social Work, Flinders University, Australia.

Dan J Stein (DJ)

SAMRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.

Matthias Brand (M)

General Psychology: Cognition and Center for Behavioral Addiction Research (CeBAR), University Duisburg-Essen, Germany.

Lior Carmi (L)

The Data Science Institute, Inter-disciplinary Center, Herzliya, Israel.

Samuel R Chamberlain (SR)

Department of Psychiatry, Faculty of Medicine, University of Southampton, Southampton, UK.
Southern Health NHS Foundation Trust, Southampton, UK.

Zsolt Demetrovics (Z)

Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary.

Naomi A Fineberg (NA)

University of Hertfordshire, Hatfield, UK, Hertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, UK.
University of Cambridge School of Clinical Medicine, Cambridge, UK.

Hans-Jürgen Rumpf (HJ)

Department of Psychiatry and Psychotherapy, University of Luebeck, Luebeck, Germany.

Murat Yücel (M)

BrainPark, School of Psychological Sciences, Turner Institute for Brain and Mental Health and Monash Biomedical Imaging Facility, Monash University, Melbourne, Victoria, Australia.

Sophia Achab (S)

Specialized Facility In Behavioral Addictions, ReConnecte, Department of Psychiatry, University Hospitals of Geneva, Generva, Switzerland.
Faculty of Medicine, Geneva University, Geneva, Switzerland.

Atul Ambekar (A)

National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.

Norharlina Bahar (N)

Department of Psychiatry and Mental Health, Hospital Selayang, Ministry of Health, Malaysia.

Alexander Blaszczynski (A)

Faculty of Science, Brain and Mind Centre, School of Psychology, University of Sydney, Sydney, Australia.

Henrietta Bowden-Jones (H)

National Centre for Gaming Disorders, London, UK.
University College London, London, UK.

Xavier Carbonell (X)

Faculty of Psychology, Education and Sports Sciences Blanquerna, Ramon Llull University, Barcelona, Spain.

Elda Mei Lo Chan (EML)

St John's Cathedral Counselling Service, and Division on Addiction, Hong Kong.

Chih-Hung Ko (CH)

Department of Psychiatry, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung City, Taiwan.

Philippe de Timary (P)

Department of Adult Psychiatry, Institute of Neuroscience, UCLouvain and Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Magali Dufour (M)

Université du Québec à Montréal, Montréal, Québec, Canada.

Marie Grall-Bronnec (M)

CHU Nantes, Department of Addictology and Psychiatry, Nantes, France.
Universités de Nantes et Tours, UMR 1246, Nantes, France.

Hae Kook Lee (HK)

Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

Susumu Higuchi (S)

National Hospital Organization, Kurihama Medical and Addiction Center, Japan.

Susana Jimenez-Murcia (S)

Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
Ciber Fisiopatología Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, Madrid, Spain.

Orsolya Király (O)

Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary.

Daria J Kuss (DJ)

International Gaming Research Unit, Psychology Department, Nottingham Trent University, Nottingham, UK.

Jiang Long (J)

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Laboratory for Experimental Psychopathology, Psychological Science Research Institute, Université Catholique de Louvain, Louvain, Belgium.

Astrid Müller (A)

Department of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hanover, Germany.

Stefano Pallanti (S)

Neuroscience Institute, University of Florence, Italy.

Marc N Potenza (MN)

Departments of Psychiatry and Neuroscience and the Child Study Center, Yale School of Medicine and Connecticut Mental Health Center, New Haven, CT, USA.

Afarin Rahimi-Movaghar (A)

Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran.

John B Saunders (JB)

Centre for Youth Substance Abuse Research, University of Queensland, Brisbane, Queensland, Australia.

Adriano Schimmenti (A)

Faculty of Human and Social Sciences, Kore University of Enna, Enna, Italy.

Seung-Yup Lee (SY)

Department of Psychiatry, Eunpyeong St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

Kristiana Siste (K)

Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Cipto Mangunkusumo Hospital, Jakarta, Indonesia.

Daniel T Spritzer (DT)

Postgraduate Program in Psychiatry and Behavioral Sciences, Federal University of Rio Grande do Sul, Brazil.

Vladan Starcevic (V)

Faculty of Medicine and Health, Sydney Medical School, Nepean Clinical School, University of Sydney, Sydney, Australia.

Aviv M Weinstein (AM)

Department of Behavioral Science, Ariel University, Israel.

Klaus Wölfling (K)

Outpatient Clinic for Behavioral Addictions, Department of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg-University Mainz, Germany.

Joël Billieux (J)

Institute of Psychology, University of Lausanne, Lausanne, Switzerland.
Health and Behaviour Institute, University of Luxembourg, Esch-sur-Alzette, Luxembourg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH